Updated: 6/9/2022

Antibiotics

0%
Topic
Review Topic
0
0
N/A
N/A
Questions
2
0
0
0%
0%
Evidence
2
0
0
Topic
  • Classification & Indications
    • Cell Wall Synthesis Inhibitors
        • Penicillins
        • (Bactericidal: inhibits bacterial cell wall synthesis via competitive inhibition of the transpeptidase enzyme)
        • Class
        • Name of Drug(s)
        • Key Indications(s)
        • Penicillin 
        • Penicillin G
        • Aqueous (crystalline) penicillin G
        • Procaine penicillin G
        • Benzathine penicillin G
        • Penicillin V
        • S. pnuemoniae
        • S. pyogenes (group A strep)
        • N. meningitidis
        • T. pallidum
        • L. monocytogenes
        • A. israelii
        • P. multocida
        • Aminopenicillins
        • Ampicillin
        • Amoxicillin
        • ↑ gram-negative coverage
        • Enterococci (group D strep)
        • All others listed above
        • Penicillinase-resistant penicillins
        • Methicillin
        • Nafcillin
        • Oxacillin
        • Cloxacillin
        • Dicloxacillin
        • Penicillinase-producing S. aureus
        • All others listed above
        • Antipseudomonal penicillins
        • Carbenicillin
        • Ticarcillin
        • Piperacillin
        • P. aeruginosa
        • Anaerobic bacteria
        • All others listed above
        • Cephalosporins
        • (Bactericidal: inhibits bacterial cell wall synthesis via competitive inhibition of the transpeptidase enzyme)
        • Class
        • Name of Drug(s)
        • Key Indication(s)
        • 1st generation 
        • Cefazolin
        •  Cephalexin
        • Gram-positives
        •  Some gram-negatives
        •  Skin infection prophylaxis
        • 2nd generation
        • Cefoxitin
        •  Cefaclor
        •  Cefuroxime
        • Gram-positives
        •  Improved gram-negative coverage
        •  Anaerobes
        • 3rd generation
        • Ceftriaxone
        •  Cefotaxime
        •  Ceftazidime
        • Serious gram-negative infections
        • Meningitis
        • Pseudomonas
        • 4th generation
        • Cefepime
        • Same coverage as cephalosporins +
        • expanded Pseudomonas coverage + 
        • expanded gram-positive coverage
        • 5th generation
        • Ceftaroline
        • Expanded gram-positive and gram-
        • negative coverage, non-suitable coverage of Pseudomonas
        • Other Cell Wall Inhibitors
        • Class
        • Name of Drug(s)
        • Key Indications(s)
        • Vancomycin
        • Vancomycin
        • MRSA
        •  Patients with PCN or ceph allergies
        •  S aureus
        •  S epidermidis
        •  C. difficile
        • Beta-lactamase inhibitors
        • Clavulanic acid
        •  Sulbactam
        •  Tazobactam
        • Gram-positive
        •  S. aureus
        •  S. epidermis
        •  Gram-negative
        •  E. coliKlebsiella
        • Carbapenems

        • Broadest activity of any antibiotic (does NOT cover MRSA, Mycoplasma, and some Pseudomonas)
        • Aztreonam
        • Aztreonam
        • Gram-negative rods
        • Aerobes
        • Difficult-to-treat hospital-acquired infections
        • Polymyxins
        • Polymyxin B
        •  Polymyxin E
        • Topical gram-negative infections
        • Bacitracin
        • Bacitracin
        • Topical gram-positive infections
    • Protein Synthesis Inhibitors
        • Anti-30S Ribosomal Subunit
        • Class
        • Name of Drug(s)
        • Key Indications(s)
        • Aminoglycosides
        • (bactericidal)
        • Gentamicin
        • Neomycin
        • Amikacin
        • Tobramycin
        • Streptomycin
        •  Severe gram-negative infections
        • Aerobes only
        • Can lead to nephrotoxicity and ototoxicity
        • Tetracyclines
        • (bacteriostatic)
        • Tetracycline
        • Doxycycline
        • Minocycline
        • Demeclocycline
        • Chlamydia
        • Rickettsia
        • Bacteria without peptidoglycan cell walls
        • Spirochetes
        • V. cholerae
        • H. pylori
        • Anti-50S Ribosomal Subunit
        • Class
        • Name of Drug(s)
        • Key Indications(s)
        • Macrolides
        • Erythromycin
        • Azithromycin
        • Clarithromycin
        • Outpatient URI, LRI
        • Atypical pneumonia
        • STDs
        • Gram-positive cocci
        • Chloramphenicol   
        • (bacteriostatic)
        • Chloramphenicol
        • H. influenzae
        • Bacterial meningitis
        • Brain abscess
        • Bacteroides fragilis
        • Clindamycin 
        • (bacteriostatic)
        • Clindamycin
        • Anaerobes above the diaphragm
        • Female GU
        • TSS  
        • Linezolid
        • (variable)
        • Linezolid
        • Resistant gram-positives (MRSA, VRE)
        • Streptogramins
        • Quinupristin
        • Dalfopristin
        • VRE
        • GAS and S. aureus skin infections
        • Note: bacteriocidal when used together
    • DNA Synthesis Inhibitors
        • Fluoroquinolones
        • (Bactericidal: inhibit DNA gyrase enzyme, inhibiting DNA synthesis)
        • Class
        • Name of Drug(s)
        • Key Indications(s)
        • 1st generation
        • 4th generation
        • Gram-negative UTIs
        • 2nd generation
        • Ciprofloxacin
        • Norfloxacin
        • Enoxacin
        • Ofloxacin
        • Levofloxacin
        • Gram-negative UTIs
        • Gram-negative GI tract
        • Pseudomonas
        • 3rd generation
        •  Gatifloxacin
        • As above + gram-positives
        • 4th generation
        • Moxifloxacin
        • Gemifloxacin
        • As above + gram-positives + anaerobes
        • Other DNA Inhibitors
        • Class
        • Name of Drug(s)
        • Key Indications(s)
        • Metronidazole
        • (bacteridical: metabolic byproducts disrupt DNA)
        • Metronidazole (Flagyl)
        • Bacteria AND protozoa
        • Anaerobes below the diaphragm
        • C. difficile
        • H. pylori
    • RNA Synthesis Inhibitors
        • Class
        • Name of Drug(s)
        • Key Indications(s)
        • Rifampin   
        • (bactericidal: inhibits RNA transcription)
        •  Rifampin
        • TB
        • Leprosy
        • H.influenzae prophylaxis
        • Antistaphylococcal
    • Mycolic Acids Synthesis Inhibitors
        • Class
        • Name of Drug(s)
        • Key Indications(s)
        • Isoniazid
        • Isoniazid
        • Latent TB
        • Can cause peripheral neuropathy
        • Elevated liver enzymes most common side effect of RIPE therapy
    • Folic Acid Synthesis Inhibitors
        • Class
        • Name of Drug(s)
        • Key Indications(s)
        • Sulfonamides
        • Sulfamethoxazole (SMX)
        • Sulfisoxazole
        • Sulfadiazine
        • Respiratory (S. pneumoniae, H. influenzae)
        • GI (enterics)
        • UTIs
        • PCP and T. gondii
        • Trimethoprim
        • Trimethoprim
        •  Sulfonamides
        • Pyrimethamine
        • Pyrimethamine
        • Malaria
        • T. gondii
    • Miscellaneous   
        • Drugs
        • Mechanism of Action
        • Indications and Side Effects
        • Pyrazinamide
        • Uncertain mechanism: potentially accumulates in cells disrupting membrane potential and fatty acid synthesis
        • Part of RIPE therapy for TB
        •  Can cause hyperuricemia and hepatoxicity
        • Ethambutol
        • Inhibits arabinosyltransferase (inhibiting production of mycobacterium cell wall)
        • Part of RIPE therapy for TB and used for M. avium-intracellulare
        •  Can cause optic neuropathy (red-green color blindness)
        • Daptomycin
        • Lipopeptide that disrupts cell membrane
        • Multi-resistant gram-positives such as MRSA and VRE
        •  Can cause myopathy (elevated CK and rhabdomyolysis

Please rate this review topic.

You have never rated this topic.

Thank you. You can rate this topic again in 12 months.

Flashcards (0)
Cards
1 of 0
Questions (2)
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Evidence (2)
VIDEOS & PODCASTS (1)
EXPERT COMMENTS (2)
Private Note